共 50 条
- [1] Effect of Abaloparatide on Fracture Incidence and Bone Mineral Density in Postmenopausal Women with Osteoporosis at Highest Risk for Fracture [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (12): : 1448 - 1448
- [2] Osteoporosis Therapy in Postmenopausal Women With High Risk of Fracture [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (07): : 715 - 716
- [3] Determinants of imminent fracture risk in postmenopausal women with osteoporosis [J]. Osteoporosis International, 2020, 31 : 2103 - 2111
- [5] Bazedoxifene reduces the risk of fracture in women with postmenopausal osteoporosis [J]. Nature Clinical Practice Rheumatology, 2008, 4 (11): : 566 - 566
- [6] Clinical evaluation of osteoporosis and fracture risk in postmenopausal women [J]. Clinical Reviews in Bone and Mineral Metabolism, 2006, 4 (1): : 15 - 23
- [9] Correction to: Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide [J]. Calcified Tissue International, 2018, 102 : 634 - 634
- [10] Prediction of Osteoporosis & fracture risk in postmenopausal Emirate women. [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (12): : 1354 - 1354